jpcv
Senior Member
- Messages
- 386
- Location
- SE coast, Brazil
Interesting links from another thread:
Lots of misinformation here. From the SEC filings and press releases:
Hemispherx did have manufacturing problems, they have now been solved. They have a primary and a secondary contract manufacturers and they are both manufacturing on an accelerated basis. They are located in Washington State and Southern California.
The price has recently gone up 167%
Ampligen is available in the U.S. - but only to existing AMP511 trial participants. No new patients, however Hemispherx continues to seek approval in the U.S.
The push seems to be to deliver to Europe through MyTomorrows which is based in Denmark and handles Early Access Programs. MyTomorrows has signed up/approved 50 pancreatic cancer patients to receive ampligen. There is an Early Access Program for CFS.
Argentina is the first country to approve Ampligen. However, much work to be done, from the most recent 10-K:
"There are a number of actions that must occur before we could be able to commence commercial sales in Argentina. Commercialization in Argentina will require, among other things, an appropriate reimbursement level, appropriate marketing strategies, completion of manufacturing preparations for launch (including possible requirements for approval of final manufacturing),....."
Hope that helps.
I have severe ME/CFS (required to participate in the trial). When I first started Ampligen, I was barely able to care for myself and had to hire drivers to get me to the infusion center. The effects were not immediate but after several months, I started getting better. I function at a much higher level on Ampligen. My labs improved too. Viral infections were under control. My natural killer cell test went from 5 to 70. Ampligen is a good drug in the hands of a bad pharma.
To answer your question, I am doing well for now.